AstraZeneca's COVID-19 Vaccine On Hold: A Reminder Product Development Is Never Straightforward
Phase III Trial Stopped A Week After Initiation
AstraZeneca – one of the frontrunners in the race to develop a COVID-19 vaccine – has voluntarily put a hold on the Phase III trial due to an adverse event.
